Medtronic plc (MDT) said Friday it received approval from the U.S. Food and Drug Administration or FDA for the DiamondTemp Ablation (DTA) system which treats patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy.
According to Medtronic, the DiamondTemp system is the first FDA-approved, temperature-controlled, irrigated radiofrequency or RF ablation system with diamonds currently available to deliver ablations.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com